Table 1_Autologous and allogeneic hematopoietic cell transplantation in children and adult

41 patients with high-risk anaplastic large cell lymphoma (ALCL) who underwent autologous (n=24) or allogeneic (n=17) hematopoietic cell transplantation (HCT) between 1997 and 2020. The data, collected by Natalie L. Smith, includes 5-year progression-free and overall survival estimates, comparing outcomes by transplant type and disease status at the time of transplant.

Use Cases

• Compare 5-year overall survival between autologous and allogeneic HCT based on the reported survival percentages.
• Analyze the impact of detectable disease at transplant on survival outcomes based on the described patient subgroups.
• Investigate temporal trends in transplant outcomes by comparing results from transplants performed in 2009 or later.
• Model survival probabilities for high-risk ALCL patients considering HCT based on the provided confidence intervals.

Strengths

• Data covers a 23-year period (1997-2020), providing a longitudinal view.
• Includes specific 5-year survival estimates with 95% confidence intervals for distinct patient groups.
• Compares two treatment modalities (autologous vs. allogeneic HCT) and the factor of disease status at transplant.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single center, which may limit generalizability.

Provenance

Source

figshare, author Natalie L. Smith.

Collection Method

Data collected on patients treated at a single center.

Time Range

1997 to 2020

Freshness

Last updated 2026-04-22 11:44:27; freshness should be verified.